Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver
dc.contributor.author | Burgess, Kimberly S. | |
dc.contributor.author | Philips, Santosh | |
dc.contributor.author | Benson, Eric A. | |
dc.contributor.author | Desta, Zeruesenay | |
dc.contributor.author | Gaedigk, Andrea | |
dc.contributor.author | Gaedigk, Roger | |
dc.contributor.author | Segar, Matthew W. | |
dc.contributor.author | Liu, Yunlong | |
dc.contributor.author | Skaar, Todd C. | |
dc.contributor.department | Department of Pharmacology and Toxicology, IU School of Medicine | en_US |
dc.date.accessioned | 2017-05-23T20:53:56Z | |
dc.date.available | 2017-05-23T20:53:56Z | |
dc.date.issued | 2015-08 | |
dc.description.abstract | Developmental changes in the liver can significantly impact drug disposition. Due to the emergence of microRNAs (miRNAs) as important regulators of drug disposition gene expression, we studied age-dependent changes in miRNA expression. Expression of 533 miRNAs was measured in 90 human liver tissues (fetal, pediatric [1-17 years], and adult [28-80 years]; n = 30 each). In all, 114 miRNAs were upregulated and 72 were downregulated from fetal to pediatric, and 2 and 3, respectively, from pediatric to adult. Among the developmentally changing miRNAs, 99 miRNA-mRNA interactions were predicted or experimentally validated (e.g., hsa-miR-125b-5p-CYP1A1; hsa-miR-34a-5p-HNF4A). In human liver samples (n = 10 each), analyzed by RNA-sequencing, significant negative correlations were observed between the expression of >1,000 miRNAs and mRNAs of drug disposition and regulatory genes. Our data suggest a mechanism for the marked changes in hepatic gene expression between the fetal and pediatric developmental periods, and support a role for these age-dependent miRNAs in regulating drug disposition. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Burgess, K. S., Philips, S., Benson, E. A., Desta, Z., Gaedigk, A., Gaedigk, R., … Skaar, T. C. (2015). Age-related changes in microRNA expression and pharmacogenes in human liver. Clinical Pharmacology and Therapeutics, 98(2), 205–215. http://doi.org/10.1002/cpt.145 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/12704 | |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/cpt.145 | en_US |
dc.relation.journal | Clinical Pharmacology and Therapeutics | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Liver | en_US |
dc.subject | Fetus | en_US |
dc.subject | Pediatric | en_US |
dc.subject | Age | en_US |
dc.subject | Development | en_US |
dc.subject | Ontogeny | en_US |
dc.title | Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver | en_US |
dc.type | Article | en_US |